Biased Agonist Pharmacochaperones of the AVP V2 Receptor May Treat Congenital Nephrogenic Diabetes Insipidus-Reference-Cited by-同舟云学术

Biased Agonist Pharmacochaperones of the AVP V2 Receptor May Treat Congenital Nephrogenic Diabetes Insipidus

Published:2009-09-03 Issue:10 Volume:20 Page:2190-2203
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Jean-Alphonse Frédéric,Perkovska Sanja,Frantz Marie-Céline,Durroux Thierry,Méjean Catherine,Morin Denis,Loison Stéphanie,Bonnet Dominique,Hibert Marcel,Mouillac Bernard,Mendre Christiane

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference37 articles.

1. Vasopressin Receptors

2. Regulation of the Vasopressin V2 Receptor by Vasopressin in Polarized Renal Collecting Duct Cells

3. Molecular Pharmacology of Human Vasopressin Receptors

4. Nephrogenic Diabetes Insipidus

5. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patologías del receptor V2 de la vasopresina: diabetes insípida nefrógena congénita y síndrome de antidiuresis inapropiada nefrógena;EMC - Pediatría;2024-09

2. Cyclic Adenosine Monophosphate Signaling in Chronic Kidney Disease: Molecular Targets and Therapeutic Potentials;International Journal of Molecular Sciences;2024-08-30

3. Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors;Nature Reviews Nephrology;2024-07-22

4. Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants;PLOS ONE;2024-05-15

5. Oxytocin and vasopressin signaling in health and disease;Trends in Biochemical Sciences;2024-04